Both in Pharmaceuticals
Agios Pharmaceuticals vs Trevi Therapeutics
Over the past year AGIO returned −23.9% and TRVI returned +26.7%; their daily moves had a correlation of 0.20.
AGIO −23.9% TRVI +26.7%Growth of $1, one year, split-adjusted
| Metric | AGIO | TRVI |
|---|---|---|
| Price | $30.55 | $13.56 |
| Market cap | $1.82B | $1.93B |
| Today | −17.94% | −1.81% |
| 1 month | −5.9% | −4.4% |
| 6 months | +8.5% | −2.2% |
| Year to date | +12.2% | +8.3% |
| 1 year | −27.2% | +28.2% |
| Revenue growth (YoY) | +259.3% | — |
| Gross margin | 93.3% | — |
| Net margin | −225.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 18.5× | — |
| Net cash | $617.6M | $318.9M |
| Dividend yield | — | — |
| Volatility (60d) | 57.3% | 39.6% |
| Short % of float | 12.2% | 14.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).